Kilitch Drugs (India) Limited Share Price & Technical Analysis
KILITCH · ₹180.6 (-2.47%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹180.6
-2.47%
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, anti…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
17% return in May, 5% avg return in past 3 year May month.
3% return in 2026, 25% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -5% | -22% | 22% | 17% | – | – | – | – | – | – | – | 3% |
| 25 | -4% | -5% | 18% | 13% | 10% | 0% | 0% | -24% | 0% | 15% | -12% | 2% | 12% |
| 24 | 16% | -10% | 0% | -9% | -8% | -3% | 12% | -11% | 0% | -8% | -6% | 2% | -26% |
| 23 | -4% | -7% | -2% | 24% | 12% | -2% | -2% | 2% | 32% | 9% | 16% | 10% | 88% |
| 22 | -14% | -26% | 1% | 8% | -11% | -12% | 5% | 3% | -4% | 3% | -12% | -1% | -59% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Strong
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, anticoagulant, narcotic, oncology, ophthalmic, antifungal, corticosteroid, anticoagulant, and other applications, as well as vaccines, veterinary products, iron supplements for anemia, Klavmox, and Onecef. It also provides oral formulations, including tablets, capsules, dry syrup, and oral powder for antibiotic, anti-diabetic, cardiovascular, and other areas; effervescent tablets and powders, such as Roipar, Duregra, and Roivit; and nutritional products, including Celtine. In addition, the company offers cosmetics, which include oil, lotion, liquid to cream, paste in skin, and personal and hair care products; herbal products for use in sore throat and prostate problems, as well as a supplement for diabetes, obesity, libido, and other conditions; ortho rehabilitation and implants; and medical devices comprising C-Seal, a skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Further, it provides PH-7 which reduces acid content of the stomach; SRO kit for treating childhood diarrhea; 9-VIT for use in surgery, extensive burns, fractures, and other trauma; and HPURE for sore throat and cough. The company exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹5.17B
P/E ratio
18.85
52W high
₹250.0
52W low
₹117.3
Volume
1,91,903
Beta
0.14
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Kilitch Drugs (India) Limited share price today?
- Kilitch Drugs (India) Limited (KILITCH) last traded around ₹180.6 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KILITCH have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KILITCH. Download the app for real-time alerts.
- How can I analyze Kilitch Drugs (India) Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.